N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine

This compound is a small molecule experimental drug with the chemical formula C19H17F2N7 and an average molecular weight of approximately 381.38 g/mol. It belongs to the class of organic compounds known as phenylpyrimidines. The drug acts primarily as a cyclin-dependent kinase 2 (CDK2) inhibitor. CDK2 is an enzyme involved in cell cycle regulation; inhibition of CDK2 can lead to cell cycle arrest and has potential applications in cancer therapy by preventing tumor cell proliferation. The compound was identified and characterized for its binding affinity to CDK2 but remains experimental with no approved clinical indications or marketed brand names reported.

Other names

5-{[5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-yl]amino}methyl)pyrimidin-2-amine